Shattuck Labs, Inc. has grown revenue 5.2% a year over three years and −37% a year over five. Revenue growth, 3-year annual rate: +5.2% (Biotechnology median +17%). Revenue growth, 5-year rate: −37%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

STTKShattuck Labs, Inc.

Healthcare

$5.66+131% 1Y

$5.66

$1.7752 weeks$8.06

Is it growing?

Watch

Revenue shrinking (−67% year on year). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 2 without data

Revenue trend−67% in a yearSEC EDGAR · Jun 30, 2026

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is STTK growing?

Shattuck Labs, Inc. has grown revenue 5.2% a year over three years and −37% a year over five.

+5.2%

Revenue growth, 3-year annual rate · Biotechnology median +17% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −37%
Revenue growth, 5-year rate · +5.2% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›